Discontinuation report NORPROLAC
Report ID | 140212 |
Drug Identification Number | 02223740 |
Brand name | NORPROLAC |
Common or Proper name | quinagolide hydrochloride |
Company Name | FERRING INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | QUINAGOLIDE |
Strength(s) | 0.025MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | (3x25mcg) |
ATC code | G02CB |
ATC description | OTHER GYNECOLOGICALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2021-10-31 |
Actual discontinuation date | 2021-06-02 |
Remaining supply date | 2021-10-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | All remaining supply of the starter packs expire Oct-2021 |
Company comments | For patients, please discuss alternative treatment options with your health care professional. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 200 YORKLAND BLVD TORONTO, ONTARIO CANADA M2J 5C1 |
Company contact information | 1-800-263-4057 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2021-06-03 | English | Compare |
v4 | 2021-06-02 | French | Compare |
v3 | 2021-06-02 | English | Compare |
v2 | 2021-06-02 | French | Compare |
v1 | 2021-06-02 | English | Compare |
Showing 1 to 5 of 5